Delivery Order SPE2DB22D3010-SPE2DB25FP3JP
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Entresto 24 mg–26 mg tablets (180 count) at a ceiling value of $2,242.14. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a ceiling value of $17,820.70. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count units) with a contract value of $6,212.25. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $5,979.12 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count unit). This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by April 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $36,034.88 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $9,378.51 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units) with a ceiling value of $10,593.59. This is a firm fixed-price, non-set-aside delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical supply vehicle running through December 2026. The work is to...
- The Defense Logistics Agency awarded a $28,354.52 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $3,560.22 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Entresto is a cardiovascular medication used in heart failure treatment, reflecting the company's role as a...
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...